PLOD3 is a multifunctional enzyme with lysyl hydroxylase, collagen galactosyltransferase as well as glucosyltransferase ability and is highly expressed and associated with the progression of lung cancer, glioma, ovarian cancer, gastric cancer, hepatocellular cancer and pancreatic cancer [39–45]. This evidence concerns the gene PLOD3 and glioma.